AAP
DNA icon

Arax Advisory Partners’s Ginkgo Bioworks DNA Stock Holding History

Arax Advisory Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78K Buy
7,868
+7,827
+19,090% +$65.5K ﹤0.01% 2917
2026
Q1 		$252 Buy
41
+38
+1,267% +$316 ﹤0.01% 3513
2025
Q4 		$25 Sell
3
-92
-97% -$991 ﹤0.01% 4006
2025
Q3 		$1.39K Buy
+95
New +$1.14K ﹤0.01% 3186
2024
Q4 		– Sell
-40
Closed -$326 – 2506
2024
Q3 		$326 Sell
40
-1
-2% -$10 ﹤0.01% 2460
2024
Q2 		$544 Buy
+41
New +$1.22K ﹤0.01% 2317

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Arax Advisory Partners's DNA Position: Q2 2026 in Review

Arax Advisory Partners increased its Ginkgo Bioworks (DNA) stake by 19,090% in Q2 2026, buying an estimated $65.5K and bringing the position to 7,868 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

Arax Advisory Partners first reported a position in DNA in Q2 2024 and has held it in 6 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Arax Advisory Partners held 7,868 shares of Ginkgo Bioworks worth $78K as of Q2 2026.
  • Arax Advisory Partners bought 7,827 Ginkgo Bioworks shares in Q2 2026, an estimated $65.5K.
  • Ginkgo Bioworks made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2917 holding.
  • Arax Advisory Partners first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 6 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.